{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:27:58Z","timestamp":1770424078741,"version":"3.49.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1093\/jac\/43.1.55","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T18:24:55Z","timestamp":1027707895000},"page":"55-60","source":"Crossref","is-referenced-by-count":15,"title":["Markedly different rates and resistance profiles exhibited by seven commonly used and newer \u03b2-lactams on the selection of resistant variants of Enterobacter cloacae"],"prefix":"10.1093","volume":"43","author":[{"given":"Wai C.","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia M.","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augustine F.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerome J.","family":"Schentag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[1999,1]]},"reference":[{"key":"key\n\t\t\t\t20170411035146_R1","doi-asserted-by":"crossref","unstructured":"Gaynes, R. P., Culver, D. H., Horan, T. C., Henderson, T. S., Tolson, J. S. & Martone, W. J. 1992 Trends in methicillin-resistant Staphylococcus aureus in United States hospitals. Infectious Diseases and Clinical Practices2, 452\u20135.","DOI":"10.1097\/00019048-199311000-00020"},{"key":"key\n\t\t\t\t20170411035146_R2","doi-asserted-by":"crossref","unstructured":"Cohen, M. L. 1992 Epidemiology of drug resistance: implications for a post-anti-microbial area. Science257, 1050\u20135.","DOI":"10.1126\/science.257.5073.1050"},{"key":"key\n\t\t\t\t20170411035146_R3","unstructured":"Wiedemann, B. & Atkinson, B. A. (1991). Susceptibility to antibiotics: species incidence and trends. In Antibiotics in Laboratory Medicine , 3rd edn, (Lorian V., ed), pp. 962\u20131062. Williams and Wilkins, Baltimore, MD."},{"key":"key\n\t\t\t\t20170411035146_R4","doi-asserted-by":"crossref","unstructured":"Schentag, J. J., Hyatt, J. M., Carr, J. B., Paladino, J. A., Birmingham, M. C., Zimmer, G. S. et al.1998 Genesis of methicillin resistant Staphylococcus aureus (MRSA), how treatment of MRSA infections has selected for vancomycin resistant Enterococcus faecium , and the importance of antibiotic management and infection control. Clinical Infectious Diseases26 , 1204\u201314.","DOI":"10.1086\/520287"},{"key":"key\n\t\t\t\t20170411035146_R5","doi-asserted-by":"crossref","unstructured":"McGowan, J. E. 1983 Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Review of Infectious Diseases5 , 1033\u201348.","DOI":"10.1093\/clinids\/5.6.1033"},{"key":"key\n\t\t\t\t20170411035146_R6","unstructured":"Pech\u00e8re, J. C., Marchou, B., Michea-Hamzehpour, M. & Auckenthaler, R. 1986 Emergence of resistance after therapy with antibiotics used alone or combined in a murine model. Journal of Antimicrobial Chemotherapy17, Suppl. A, 11\u20138."},{"key":"key\n\t\t\t\t20170411035146_R7","doi-asserted-by":"crossref","unstructured":"Michea-Hamzehpour, M., Auckenthaler, R., Regamey, P. & Pech\u00e8re, J. C. 1987 Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis. Antimicrobial Agents and Chemotherapy31, 1803\u20138.","DOI":"10.1128\/AAC.31.11.1803"},{"key":"key\n\t\t\t\t20170411035146_R8","doi-asserted-by":"crossref","unstructured":"Milatovic, D. & Braveny, I. 1987 Development of resistance during antibiotic therapy. European Journal of Clinical Microbiology6, 234\u201344.","DOI":"10.1007\/BF02017607"},{"key":"key\n\t\t\t\t20170411035146_R9","doi-asserted-by":"crossref","unstructured":"Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P. et al. 1991Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Annals of Internal Medicine115, 585\u201390.","DOI":"10.7326\/0003-4819-115-8-585"},{"key":"key\n\t\t\t\t20170411035146_R10","doi-asserted-by":"crossref","unstructured":"Stapleton, P., Shannon, K. & Phillips, I. 1995 The ability of \u03b2-lactam antibiotics to select mutants with depressed \u03b2-lactamase synthesis from Citrobacter freundii.Journal of Antimicrobial Chemotherapy36, 483\u201396.","DOI":"10.1093\/jac\/36.3.483"},{"key":"key\n\t\t\t\t20170411035146_R11","unstructured":"Fung-Tomc, J. C., Gradelski, E., Huczko, E., Dougherty, T. J., Kessler, R. E. & Bonner, D. P. 1996 Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy40,1289\u2013 93."},{"key":"key\n\t\t\t\t20170411035146_R12","doi-asserted-by":"crossref","unstructured":"Gaston, M. A. 1988Enterobacter : an emerging nosocomial pathogen. Journal of Hospital Infection11, 197\u2013208.","DOI":"10.1016\/0195-6701(88)90098-9"},{"key":"key\n\t\t\t\t20170411035146_R13","unstructured":"National Committee for Clinical Laboratory Standards. (1993). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A3 . NCCLS, Villanova, PA."},{"key":"key\n\t\t\t\t20170411035146_R14","unstructured":"Ehrhardt, A. F., Sanders, C. C., Romero, J. R. & Leser, J. S.1996 Sequencing and analysis of four new Enterobacter ampD alleles. Antimicrobial Agents and Chemotherapy40, 1953\u20136."},{"key":"key\n\t\t\t\t20170411035146_R15","unstructured":"Buscher, K. H., Cullmann, W., Dick, W. & Stieglitz, M.1987 Selection frequency of resistant variants by various \u03b2-lactam antibiotics in clinical Enterobacter cloacae isolates. Chemotherapy33, 40\u201351."},{"key":"key\n\t\t\t\t20170411035146_R16","doi-asserted-by":"crossref","unstructured":"Michea-Hamzehpour, M. & Pech\u00e8re, J. C. 1989 How predictable is development of resistance after beta-lactam therapy in Enterobacter cloacae infection? Journal of Antimicrobial Chemotherapy24, 387\u201395.","DOI":"10.1093\/jac\/24.3.387"},{"key":"key\n\t\t\t\t20170411035146_R17","doi-asserted-by":"crossref","unstructured":"Rasmussen, B. A. & Bush, K. (1997). Carbapenem-hydrolysing \u03b2 -lactamases. Antimicrobial Agents and Chemotherapy41, 223\u201332","DOI":"10.1128\/AAC.41.2.223"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/43\/1\/55\/13056589\/JAC43155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T03:23:26Z","timestamp":1583292206000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/43.1.55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1999,1]]},"published-print":{"date-parts":[[1999,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/43.1.55","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}